SCM
SGMO

Stevens Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Stevens Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-27,981
Closed -$310K – 1193
2015
Q2 		$310K Buy
+27,981
New +$361K 0.01% 744
2014
Q4 		– Sell
-31,373
Closed -$338K – 1201
2014
Q3 		$338K Buy
+31,373
New +$410K 0.01% 695

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Stevens Capital Management's SGMO Position: Q3 2015 in Review

Stevens Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2015, closing a stake of 27,981 shares — an estimated $310K sold.

Stevens Capital Management first reported a position in SGMO in Q3 2014 and held it in 2 quarters. The position peaked at $338K in Q3 2014. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

  • Stevens Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
  • Stevens Capital Management sold 27,981 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $310K.
  • Stevens Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2014 and held it in 2 quarters.
  • Stevens Capital Management's SANGAMO THERAPEUTICS INC position peaked at $338K in Q3 2014.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on Stevens Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.